ArticleDiabetes research and clinical practice2026
Trends in comorbidities and multimorbidity among adults with recently diagnosed diabetes: United States, 1999-2023.
Article in Diabetes research and clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsComorbidities are common at diabetes onset and may influence long-term outcomes. We examined national trends in the prevalence, number, and multimorbidity patterns among U.S. adults with newly ascertained diabetes, distinguishing concordant metabolic risk factors, concordant vascular diseases, and discordant conditions.
methodsWe analyzed National Health and Nutrition Examination Survey data (1999-August 2023) for adults (≥20 years) with newly ascertained diabetes (diagnosed at the survey or ≤2 years prior; n = 4,243). Age-adjusted prevalence of 13 comorbidities, mean comorbidity count, and multimorbidity patterns were estimated across three periods. Trends were assessed using logistic and linear regression and pattern distributions using chi-square tests.
resultsObesity increased from 58.3% (1999-2006) to 71.0% (2015-2023) (p = 0.0003); Chronic lung disease rose from 15.4% to 22.8% (p = 0.007). Chronic kidney disease (∼30%) and cardiovascular disease (11.8%-14.1%) were stable. Arthritis (∼40%), sleep disorders (29.2%-38.5%), and dental caries (∼30%) were common but stable. The mean comorbidity count increased from 4.25 to 4.51 (p = 0.038), with greater overlap of concordant and discordant conditions (p = 0.008).
conclusionsFrom 1999 to 2023, obesity, chronic lung disease, and total number of comorbidities increased among adults with new diabetes. Multimorbidity patterns increasingly encompassed both concordant and discordant conditions, potentially complicating management and worsening outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.